Roles and mechanisms of NSUN2-mediated RNA m5C modification in cancer progression and immune modulation

Chunhong Li1, Yixiao Yuan2, Xiulin Jiang2

  • 1Department of Oncology, Suining Central Hospital, Suining, Sichuan, China.

Frontiers in Immunology
|November 19, 2025
PubMed

Insights

The RNA methyltransferase NSUN2 (NOP2/Sun RNA methyltransferase 2) drives cancer progression and immune evasion by regulating gene expression and the tumor microenvironment. Targeting NSUN2 offers potential for novel cancer therapies.

Area of Science:

  • Molecular Biology
  • Cancer Biology
  • Immunology

Background:

  • RNA epigenetic modifications, particularly 5-methylcytosine (m5C), are crucial for gene expression regulation in cancer.
  • NSUN2 (NOP2/Sun RNA methyltransferase 2) is a key enzyme responsible for m5C modification across various RNA species.

Purpose of the Study:

  • To review the multifaceted roles of NSUN2 in cancer progression, including its impact on cellular functions and the tumor immune microenvironment.
  • To discuss the clinical implications of NSUN2 as a biomarker and therapeutic target in oncology.

Main Methods:

  • Literature review of studies investigating NSUN2 function in cancer.
  • Analysis of NSUN2's molecular mechanisms in RNA modification, stability, processing, export, and translation.
  • Examination of NSUN2's influence on tumor-associated pathways and the tumor immune microenvironment.

Main Results:

  • NSUN2 promotes tumorigenesis by enhancing cell proliferation, drug resistance, epithelial-mesenchymal transition, and metabolic reprogramming.
  • Dysregulated NSUN2 expression correlates with poor patient prognosis and suggests its utility as a biomarker.
  • NSUN2 significantly modulates the tumor immune microenvironment by affecting immune checkpoint molecules, cytokines, and immune cell functions, leading to immune evasion.

Conclusions:

  • NSUN2 plays a critical role in both cancer cell-intrinsic processes and the modulation of anti-tumor immunity.
  • Understanding NSUN2's mechanisms provides a foundation for developing targeted cancer therapies and improving immunotherapy strategies.
  • Further research into NSUN2 is warranted to fully explore its therapeutic potential in oncology.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.8K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
23.9K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.6K
RNA Stability01:53

RNA Stability

Intact DNA strands can be found in fossils, while scientists sometimes struggle to keep RNA intact under laboratory conditions. The structural variations between RNA and DNA underlie the differences in their stability and longevity. Because DNA is double-stranded, it is inherently more stable. The single-stranded structure of RNA is less stable but also more flexible and can form weak internal bonds. Additionally, most RNAs in the cell are relatively short, while DNA can be up to 250 million...
35.6K
Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
6.8K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.9K